When does proton pump inhibitor treatment become long term? A scoping review
Open Access
- 15 February 2021
- journal article
- review article
- Published by BMJ in BMJ Open Gastroenterology
- Vol. 8 (1), e000563
- https://doi.org/10.1136/bmjgast-2020-000563
Abstract
Objective Proton pump inhibitor (PPI) use has risen substantially, primarily driven by ongoing use over months to years. However, there is no consensus on how to define long-term PPI use. Our objectives were to review and compare definitions of long-term PPI use in existing literature and describe the rationale for each definition. Moreover, we aimed to suggest generally applicable definitions for research and clinical use. Design The databases PubMed and Cochrane Library were searched for publications concerning long-term use of PPIs and ClinicalTrials.gov was searched for registered studies. Two reviewers independently screened the titles, abstracts, and full texts in two series and subsequently extracted data. Results A total of 742 studies were identified, and 59 met the eligibility criteria. In addition, two ongoing studies were identified. The definition of long-term PPI use varied from >2 weeks to >7 years. The most common definition was ≥1 year or ≥6 months. A total of 12/61 (20%) of the studies rationalised their definition. Conclusion The definitions of long-term PPI treatment varied substantially between studies and were seldom rationalised. In a clinical context, use of PPI for more than 8 weeks could be a reasonable definition of long-term use in patients with reflux symptoms and more than 4 weeks in patients with dyspepsia or peptic ulcer. For research purposes, 6 months could be a possible definition in pharmacoepidemiological studies, whereas studies of adverse effects may require a tailored definition depending on the necessary exposure time. We recommend to always rationalise the choice of definition.Keywords
This publication has 71 references indexed in Scilit:
- Inappropriate use of proton pump inhibitors among medical inpatients: a questionnaire-based observational studyJRSM Short Reports, 2013
- Safety and efficacy of long-term esomeprazole 20 mg in Japanese patients with a history of peptic ulcer receiving daily non-steroidal anti-inflammatory drugsBMC Gastroenterology, 2013
- Patient Selection for Therapy Reduction after Long-Term Daily Proton Pump Inhibitor Treatment for Gastro-Oesophageal Reflux Disease: Trial and ErrorDigestion, 2013
- Association Between Proton Pump Inhibitor Use and Anemia: A Retrospective Cohort StudyDigestive Diseases and Sciences, 2011
- Effect of Proton-Pump Inhibitor Therapy on Serum Chromogranin A LevelDigestion, 2011
- The potential therapeutic effect of melatonin in gastro-esophageal reflux diseaseBMC Gastroenterology, 2010
- Chronic Proton Pump Inhibitor Therapy Associated with Increased Development of Fundic Gland PolypsDigestive Diseases and Sciences, 2009
- Helicobacter pylori eradication in long‐term proton pump inhibitor users is highly cost‐effective: economic analysis of the HELPUP trialAlimentary Pharmacology & Therapeutics, 2008
- Does long-term medication with a proton pump inhibitor induce a tolerance to H2 receptor antagonist?The Esophagus, 2007
- Use of anti-secretory medication: a population-based cohort studyAlimentary Pharmacology & Therapeutics, 2004